News

Proteomics signs deal for distribution of PromarkerD in Italy – Biotech Dispatch

Previously we focused on the more sophisticated mass spectrometry test, but the release of this easy-to-use, higher throughput immunoassay platform opens up many more market opportunities,” he [Managing Director Dr. Richard Lipscombe] said.

“The immunoassay (ELISA) technology allows hundreds of blood samples to be analysed quickly as a part of a panel of routine blood tests.”

Article: Proteomics signs deal for distribution of PromarkerD in Italy

Subscribe
  • This field is for validation purposes and should be left unchanged.